DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rallied 2.94% to $199.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.75% to 7,394.30 and the Dow Jones Industrial Average rising 1.86% to 50,848.75.
Biogen Inc. closed 2.92% short of its 52-week high of $205.97, which the company reached on May 13th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.07% to $238.33, Pfizer Inc. $(PFE)$ rose 2.23% to $26.17, and AbbVie Inc. $(ABBV)$ fell 0.08% to $224.77.
Trading volume (909,729) remained 312,430 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 11, 2026 17:00 ET (21:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments